Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jun;36(6):1614-1619.
doi: 10.1111/jgh.15325. Epub 2020 Dec 2.

Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy

Shao-Yi Cheng  1   2 , Chu-Fen Chen  2 , Hsien-Chin He  2 , Li-Chun Chang  3 , Wen-Feng Hsu  4 , Ming-Shiang Wu  3 , Han-Mo Chiu  3
Affiliations
Observational Study

Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy

Shao-Yi Cheng et al. J Gastroenterol Hepatol. 2021 Jun.

Abstract

Background and aim: During this COVID-19 pandemic, Taiwan is one of the few countries where fecal immunochemical test and endoscopic activity for colorectal cancer screening keeps ongoing. We aimed to investigate how screening uptake and colonoscopy rate were affected in one of the biggest screening hubs in Northern Taiwan.

Methods: We conducted a prospective observational study tracing and analyzing the screening uptake and the trend of compliance to diagnostic colonoscopy in fecal immunochemical test-positive subjects in the National Taiwan University Hospital screening hub since the outbreak of COVID-19 and compared it with that of the corresponding periods in the past 3 years. Cancellation and rescheduling rates of colonoscopy and related reasons were also explored.

Results: Screening uptake during December 2019 to April 2020 was 88.8%, which was significantly lower than that in the corresponding period of the past 3 years (91.2-92.7%, P for trend < 0.0001). Colonoscopy rate in this period was 66.1%, which was also significantly lower than that in the past 3 years (70.2-77.5%, P for trend = 0.017). Rescheduling or cancellation rate was up to 10.9%, which was significantly higher than that in the past 3 years (P for trend = 0.023), and half of them was due to the fear of being infected.

Conclusion: Fecal immunochemical test screening was significantly affected by COVID-19 pandemic. In order to resume the practice in COVID-19 era, screening organizers should consider various approaches to secure timely diagnosis of colorectal cancer.

Keywords: COVID-19; Colonoscopy; Colorectal cancer; Screening.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chronological events showing the correlation between confirmed cases and cancellations and rescheduling cases
See this image and copyright information in PMC

References

    1. Chiu HM, Chen SL, Yen AM et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer 2015; 121: 3221–3229. - PMC - PubMed
    1. Corley DA, Jensen CD, Quinn VP et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA 2017; 317: 1631–1641. - PMC - PubMed
    1. Lee YC, Fann JC, Chiang TH et al. Time to colonoscopy and risk of colorectal cancer in patients with positive results from fecal immunochemical tests. Clin. Gastroenterol. Hepatol. 2019; 17: 1332–1340 e3. - PubMed
    1. Beshara A, Ahoroni M, Comanester D et al. Association between time to colonoscopy after a positive guaiac fecal test result and risk of colorectal cancer and advanced stage disease at diagnosis. Int. J. Cancer 2020; 146: 1532–1540. - PubMed
    1. Wang CJ, Ng CY, Brook RH. Response to COVID‐19 in Taiwan: big data analytics, new technology, and proactive testing. JAMA 2020; 323: 1341–1342. - PubMed

Publication types

MeSH terms